ArticleCardiovascular research2025

REPRIEVE and CANTOS trials: lessons learned towards eliminating cardiovascular disease in human immunodeficiency virus by combined targeting of LDL and inflammation.

Annet KiraboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.